(Reuters) - The European Medicines Agency said on Tuesday it has received an application for marketing authorization for Moderna Inc's COVID-19 vaccine candidate.

(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)

General News Reuters

Moderna (MRNA) Quickly Pares Gain, Still Up 4.3%December 1, 2020 10:36 AM